The contribution of gC1qR/p33 in infection and inflammation

Immunobiology

Volumn 212, Issue 4-5, 2007, Pages 333-342

  Peerschke, Ellinor I B ^a   Ghebrehiwet, Berhane ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

gC1qR; Infection; Inflammation

Indexed keywords

BACTERIAL ANTIGEN; BRADYKININ; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C1Q RECEPTOR; COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN G1 ANTIBODY; KALLIKREIN; KININ; LOW MOLECULAR WEIGHT KININOGEN; PROTEIN A; PROTEIN P33; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CELL ADHESION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DISEASE COURSE; DRUG MECHANISM; ENDOCARDITIS; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; LYMPHOCYTE PROLIFERATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; VIRUS INFECTION; VIRUS STRAIN;

EID: 34249657934     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.11.011     Document Type: Article

References (72)

1. Agah R., Bandi V., and Gutnurparlli K.K. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intens. Care Med. 23 (1999) 793-796
2. Agostoni A., Cicardi M., and Cugno M. Angioedema due to ACE inhibitors. Immunopharmacology 15 (1999) 21-25
3. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikrein, kininogen and kinases. Pharmacol. Rev. 44 (1992) 1-80
4. Braun L., Ghebrehiwet B., and Cossart P. gC1q-R/p32, a C1q-binding protein is a novel receptor for Listeria monocytogenes. EMBO J. 19 (2000) 1458-1466
5. Chen A., Gaddipati S., Volkman D.J., Peerschke E.I.B., and Ghebrehiwet B. Human T cells possess specific receptors for C1q: role in activation and proliferation. J. Immunol. 153 (1994) 1430-1440
6. Colman R.W., Pixley R.A., Najamunnisa S., Yan W., Wang J., Mazar A., and McRae K.R. Binding of high molecular weight kininogen to human umbilical vein endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100 (1997) 1481-1487
7. Dean D.E., Schultz D.L., and Powers R.H. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J. Forensic Sci. 46 (2001) 1239-1243
8. Dedio J., Jahnen-Dechent W., Bachmann M., and Muller-Esterl W. The multiligand-binding protein gC1q-R, putative C1q receptor, is a mitochondrial protein. J. Immunol. 160 (1998) 3534-3542
9. Erdos E.G., and Sloane S.M. An enzyme in human plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11 (1962) 585-592
10. Feng X., Tonnesen M.G., Peerschke E.I.B., and Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J. Immunol. 168 (2002) 2441-2448
11. Fields T.R., Kaplan A.P., and Ghebrehiwet B. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J. Allergy Clin. Immunol. 72 (1983) 54-60
12. Ghebrehiwet B., and Peerschke E.I.B. Structure and function of gC1q-R a multiligand binding membrane protein. Immunobiology 199 (1998) 225-238
13. Ghebrehiwet B., Lim B.-L., Peerschke E.I.B., Willis A.C., and Reid K.B.M. Isolation cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular 'heads' of C1q. J. Exp. Med. 179 (1994) 1809-1821
14. Ghebrehiwet B., Lim B.-L., Kumar R., Feng X., and Peerschke E.I.B. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins is involved in inflammation and infection. Immunol. Rev. 180 (2001) 65-77
15. Ghebrehiwet B., Jesty J., and Peerschke E.I.B. gC1q-R/p33: structure-function predictions from the crystal structure. Immunobiology 205 (2002) 421-432
16. Ghebrehiwet B., Cebada Mora C., Tantral L., and Peerschke E.I.B. gC1qR/p33 serves as a molecular bridge between the complement and contact systems and is an important catalyst in inflammation. Current topics in complement. Adv. Exp. Med. Biol. 586 (2006) 95-105
17. Greengard J.S., and Griffin J.H. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 23 (1984) 6863-6869
18. Guo N., Weremowicz S., Lynch N., Schwaeble W., Lim B.-L., Morton C.C., Peerschke E.I.B., Reid K.B.M., Ghebrehiwet B., and Sastry K.N. Assignment of gC1q-R, the C1q globular domain binding protein (C1qBP) to human chromosome band 17p13.3 by in situ hybridization. Cytogenet. Cell Genet. 77 (1997) 283-284
19. Hasan A.A.K., Cines D.B., Herwald H., Schmaier A.H., and Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270 (1995) 19256-119261
20. Hasan A.A.K., Zisman T., and Schmaier A.H. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc. Natl. Acad. Sci. USA 95 (1998) 3615-3620
21. Herwald H., Hasan A.A.K., Godovac-Zimmermann J., Schmaier A.H., and Müller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270 (1995) 14634-14642
22. Herwald H., Dedio J., Kellner R., Loos M., and Müller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J. Biol. Chem. 271 (1996) 13040-13047
23. Jiang J., Zhang Y., Krainer A., and Xu R.-M. Crystal structure of p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. USA 96 (1999) 3572-3577
24. Jonquieres R., Pizzaro-Cerdà J., and Cossart P. Synergy between the N- and C-terminal domains of InlB for efficient invasion of non-phagocytic cells by Listeria monocytogenes. Mol. Microbiol. 42 (2001) 955-965
25. Joseph K., Ghebrehiwet B., Peerschke E.I.B., Reid K.B.M., and Kaplan A.P. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor which binds to the globular "heads" of C1q (gC1q-R). Proc. Natl. Acad. Sci. USA 93 (1996) 8552-8557
26. Joseph K., Ghebrehiwet B., and Kaplan A.P. Cytokeratin-1 and gC1q-R mediate high molecular weight kininogen binding to endothelial cells. Clin. Immunol. 92 (1999) 246-255
27. Joseph K., Tholanikunnel B.G., Ghebrehiwet B., and Kaplan A.P. Interaction of high molecular weight kininogen binding proteins with each other. J. Thromb. Haemost. 91 (2004) 61-70
28. Kaplan A.P. Mechanisms of bradykinin formation. In: Greaves M.W., and Kaplan A.P. (Eds). Urticaria and Angioedema (2004), Marcel Dekker Inc., NY 51-72
29. Kaplan A.P. C1 inhibitor deficiency. In: Greaves M.W., and Kaplan A.P. (Eds). Urticaria and Angioedema (2004), Marcel Dekker Inc., NY 303-320
30. Kittleson D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., and Hahn Y.S. Interaction between complement receptor gC1q-R and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106 (2000) 1239-1249
31. Lim B.-L., Preissner K., Ghebrehiwet B., Leigh L.E.A., and Reid K.B.M. The binding protein for globular "heads" of complement C1q, gC1q-R: functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 271 (1996) 26739
32. Lim B.-L., White R.A., Hummel G.S., Mak S.-C., Schwaeble W.J., Reid K.B.M., Peerschke E.I.B., and Ghebrehiwet B. Characterization of the murine gene for gC1q-BP (gC1q-R), a novel cell protein that binds the globular heads of C1q, vitronectin, high molecular weight kininogen and factor XII. Gene 209 (1998) 229-237
33. Lim B.-L., Tye A.J., Guo N., Sastry K.N., Peerschke E.I.B., and Ghebrehiwet B. The human gC1q-R/p33 gene (C1qBP): genomic organization and promoter analysis. J. Biol. Chem. 276 (2001) 17069-17075
34. Lynch N.J., Reid K.B.M., van den Berg R.H., Daha M.R., Leigh L.E.A., Lim B.-L., Ghebrehiwet B., and Schwaeble W.J. The murine homologues of gC1qBP, a 33 kDa protein that binds to the globular 'heads' of C1q. FEBS Lett. 418 (1997) 111-114
35. Mahdi F., Shariat-Madar Z., Todd III R.F., Figueroa C.D., and Schmaier A.H. Expression and localization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 97 (2001) 2342-2350
36. Mahdi F., Shariat-Madar Z., Figueroa C.D., and Schmaier A.H. Factor XII interacts with multiprotein assembly of urokinase plasminogen activator receptor, gC1q-R and cytokeratin 1 on endothelial cell membranes. Hemost. Thromb. Vasc. Biol. 99 (2002) 3585-3596
37. Marino M., Banerjee M., Jonquieres R., Cossart P., and Ghosh P. GW domains of the Listeria monocytogenes invasion protein InlB are SH3-like and mediate binding of host ligands. EMBO J. 21 (2002) 5623-5634
38. Marques G., Anton L.C., Barrio E., Sanchez A., Ruiz S., Gavilanes F., and Vivanco F. Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J. Biol. Chem. 268 (1993) 10393-10402
39. Molinaro G., Cugno M., and Perez M. ACE-inhibitor-associated angioedema is characterized by a slower degradation of desarginine(9)-bradykinin. J. Pharmacol. Exp. Ther. 303 (2002) 232-237
40. Mori K., and Nagasawa S. Studies on human high molecular (HMW) kininogen. II. Structural changes in HMW kininogen by the action of human plasma kallikrein. J. Biochem. 89 (1981) 1465-1473
41. Nguyen T., Ghebrehiwet B., and Peerschke E.I.B. Staphylococcus aureus protein A recognizes platelet gC1q-R/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 68 (2000) 2061-2068
42. Niemann H.H., Schubert W.-F., and Heinz D.W. Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect. 6 (2004) 101-112
43. Panessa-Warren, B.S., Wong, S., Ghebrehiwet, B., Tortora, G.T., Warren, J., 2002. Carbon nanotube membrane probes: immuno-labelling by LM, TEM & FESEM. In: Voelkl, E., Piston, D., Gauvin, R., Lockley, A., Bailey, G., McKernan, S. (Eds.), Microscopy and Microanalysis, vol. 8, suppl. 2. Cambridge University Press, NY, pp. 726-727.
44. Peerschke E.I.B., Minta J.O., Zhou S.Z., Bini A., Gotlieb A., Colman R.W., and Ghebrehiwet B. Expression of gC1qR/p33 and its major ligands in human atherosclerotic lesions. Mol. Immunol. 41 (2004) 759-766
45. Peerschke E.I., Bayer A.S., Ghebrehiwet B., and Xiong Y.Q. gC1qR/p33 blockade reduces Staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis. Infect. Immun. 74 (2006) 4418-4423
46. Peerschke E.I.B., Yin W., Grigg S.E., and Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. Thromb. Haemost. 4 (2006) 2035-2042
47. Peterson K., Zhang W., Lu P.D., Keilbaugh S.A., Peerschke E.I., and Ghebrehiwet B. The C1q binding membrane proteins cC1q-R and gC1q-R, are released from activated cells. Subcellular localization and immunochemical characterization. Clin. Immunol. Immunopathol. 84 (1997) 17-26
48. Pizzaro-Cerdà J., Sousa S., and Cossart P. Exploitation of host cell cytoskeleton and signalling during L. monocytogenes entry into mammalian cells. C. R. Biol. 327 (2004) 115-123
49. Pupo A.S., and Minneman K.P. Specific interactions between gC1q-R and alpha 1-adrenoreceptor subtypes. J. Recept. Signal Transduct. Res. 23 (2003) 185-195
50. Reddigari S.R., Shibayama Y., Brunnee T., and Kaplan A.P. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268 (1993) 11982-11987
51. Reddigari S.R., Kuna P., Miragliotta G.F., Shibayama Y., Nishikawa K., and Kaplan A.P. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood 81 (1993) 1306-1311
52. Regoli D., and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32 (1980) 1-46
53. Rety S., Salamitou S., Garcia-Verdugo I., Hulmes D.J.S., Le Hagarat F., Chaby R., and Lewit-Bentley A. The crystal structure of the Bacillus anthracis spore surface protein BclA shows remarkable similarity to mammalian proteins. J. Biol. Chem. 280 (2005) 43073-43078
54. Rozanov D.V., Ghebrehiwet B., Ratnikov B.I., Monosov E.Z., Deryugina E.I., and Strongin A. The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT-MMP) directly binds to gC1q-R, a compartment-specific chaperone-like regulatory protein. FEBS Lett. 571 (2002) 51-57
55. Rubinstein D.B., Stortchevoi A., Boosalis M., Ashfaq R., Ghebrehiwet B., Peerschke E.I.B., Calvo F., and Gillaume T. Receptor for the globular heads of C1q (gC1q-R; p33; Hyaluronan-binding protein is preferentially expressed by adenocarcinoma cells. Int. Cancer Res. 110 (2004) 741-750
56. Schmaier A.H., Kuo A., Lundberg D., Murray S., and Cines D.B. Then expression of high molecular weight kininogen on human umbilical vein endothelial cells. J. Biol. Chem. 263 (1988) 16327-16333
57. Sheikh I.A., and Kaplan A.P. Studies of the digestion of bradykinin, lysyl bradykinin and des-arg9 bradykinin by angiotensin converting enzyme. Biochem. Pharmacol. 35 (1986) 1951-1957
58. Sheikh I.A., and Kaplan A.P. Studies of the digestion of bradykinin, lysyl bradykinin and kinin degradation products to carboxypeptidase A, B, and N. Biochem. Pharmacol. 35 (1986) 1957-1963
59. Shen Y., Naujokas M., Park M., and Ireton K. Internalin B internalization of Listeria is mediated by Met receptor tyrosine kinase. Cell 103 (2000) 501-510
60. Silverberg M., Dunn J.T., Garen L., and Kaplan A.P. Autoactivation of human Hageman factor. J. Biol. Chem. 255 (1980) 7281-7286
61. Storz P., Hausser A., Link G., Dedio J., Ghebrehiwet B., Pfizenmaier K., and Johannes F.-J. Protein kinase C μ is regulated by the multifunctional chaperon protein p32. J. Biol. Chem. 275 (2000) 24601-24607
62. Sullam P.M. Host-pathogen interaction in the development of bacterial endocarditis. Curr. Opin. Infect. Dis. 7 (1994) 304-309
63. Sylvestre P., Couture-Tosi E., and Mock M. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol. Microbiol. 45 (2002) 169-178
64. Tantral L., Panessa-Warren B.J., Tortora G.T., Wong S.S., Warren J.B., and Ghebrehiwet B. The process of B. cereus spore attachment induces upregulation of cell surface gC1q-R/p33. Mol. Immunol. Abstr. 41 (2004) 333
65. Tom B., Dendorfer A., and deVries R. Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br. J. Pharmacol. 137 (2002) 276-284
66. van Iwaarden F., deGroot P.G., and Bouma B.N. The binding of high molecular weight kininogen to endothelia cells. J. Biol. Chem. 263 (1988) 4698-4703
67. van Leuwen H.C., and O'Hare P. Retargeting of the mitochondrial protein p32/gC1qR to a cytoplasmic compartment and the cell surface. J. Cell Sci. 114 (2001) 2115-2123
68. Vleming W., van Amsterdam J.G., Stricker B.H., and de Wildt D.J. ACE inhibitor-induced AE. Incidence, prevention and management. Drug Safety 18 (1998) 171-188
69. Yang H.Y.T., and Erdos E.G. Second kininase in human blood plasma. Nature 215 (1967) 1402-1403
70. Yao Z.Q., Eisen-Vandervelde A., Ray S., and Hahn Y.S. HCV core/gC1q-R interaction arrests T cell cycle progression through stabilization of cell cycle inhibitor p27Kip1. Virology 314 (2003) 271-282
71. Yao Z.Q., Waggoner S.N., Cruise M.W., Hall C., Xie X., Oldach D.W., and Hahn Y.S. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T cell function. J. Virol. 79 (2005) 15417-15429
72. Yao Z.Q., Shata M.T., Tricoche N., Shan M.M., Brotman B., Pfahler W., Hahn Y.S., and Prince A.M. gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection. Virology 346 (2006) 324-337